Clinical reference Biomarker Directory
Back to directory

Inhibin B

Established

Inhibin B assesses ovarian reserve (cycle-dependent, largely superseded by AMH) and male Sertoli cell function.

Also known as Inhibin B
In plain language

Inhibin B reflects ovarian egg supply in women (though AMH is now generally preferred for this) and active sperm production in men, helping distinguish different causes of male infertility.

Biomarker & context

Inhibin B is a hormone produced by ovarian granulosa cells (in women) and testicular Sertoli cells (in men), used as a marker of ovarian reserve and, separately, active spermatogenesis.

What it indicates

In women, inhibin B is an older, cycle-dependent alternative marker of ovarian reserve, though AMH has generally superseded it due to AMH's cycle-independence; it also serves as a component of some granulosa cell tumor monitoring panels. In men, low inhibin B reflects impaired Sertoli cell function and reduced spermatogenesis, used in male infertility evaluation.

Diagnosis & clinical testing

Measured via serum immunoassay; in ovarian reserve testing, inhibin B must be drawn on a specific day of the menstrual cycle (typically day 3), unlike AMH, which can be measured any day.

Guiding treatment

Low inhibin B in male infertility evaluation supports a testicular (rather than obstructive) cause of low sperm count, influencing whether further testicular biopsy or genetic testing is pursued.

Clinical significance

Requires specific-day cycle timing in women, unlike AMH, which can be measured any day.

References
  1. General reproductive endocrinology reference literature on inhibin B in ovarian reserve and male infertility evaluation.